Literature DB >> 26983705

Mechanisms of the Macrolide-Induced Inhibition of Superoxide Generation by Neutrophils.

Kohji Nozoe1, Yoshitomi Aida2, Takao Fukuda1, Terukazu Sanui1, Fusanori Nishimura1.   

Abstract

The effect of macrolides on the superoxide (O2 (-)) production by neutrophils was studied. Resting neutrophils become primed by lipopolysaccharide (LPS) or N-formyl-methionyl-leucyl-phenylalanine (fMLP), and primed neutrophils generate O2 (-) in response to fMLP or adhesion, respectively. Both LPS-primed fMLP-stimulated O2 (-) generation by macrolide-treated neutrophils and adhesion-stimulated O2 (-) generation by macrolide-treated fMLP-primed neutrophils were inhibited. Macrolide inhibition of O2 (-) generation was dependent on serum or pH. Serum could be substituted by NaHCO3. The intensity of inhibition was azithromycin = roxithromycin > clarithromycin > erythromycin, in that order. Non-antimicrobial derivatives of erythromycin, that is, EM703 and EM900, inhibited O2 (-) generation at pH 7.4. NH4Cl abolished the activity of azithromycin (AZ) only when added to neutrophils with AZ but not after incubation with AZ, suggesting that NH4Cl prevented the influx of AZ. AZ did not affect the expression of alkaline phosphatase, CD11b, and cytochrome b558 in both resting and LPS-primed neutrophils. These results suggested that macrolides did not affect granule mobilization but inhibited O2 (-) generation selectively.

Entities:  

Keywords:  EM703; azithromycin; macrolides; neutrophils; superoxide anion

Mesh:

Substances:

Year:  2016        PMID: 26983705     DOI: 10.1007/s10753-016-0333-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils.

Authors:  M T Labro; J el Benna; C Babin-Chevaye
Journal:  J Antimicrob Chemother       Date:  1989-10       Impact factor: 5.790

2.  Chemoattractant-regulated mobilization of a novel intracellular compartment in human neutrophils.

Authors:  N Borregaard; L J Miller; T A Springer
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

3.  Priming of neutrophils by lipopolysaccharide for enhanced release of superoxide. Requirement for plasma but not for tumor necrosis factor-alpha.

Authors:  Y Aida; M J Pabst
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

4.  Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes.

Authors:  W Lee Hand; Debra L Hand; Yvonne Vasquez
Journal:  Diabetes Res Clin Pract       Date:  2006-09-07       Impact factor: 5.602

5.  Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly.

Authors:  F R DeLeo; J Renee; S McCormick; M Nakamura; M Apicella; J P Weiss; W M Nauseef
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

6.  Intracellular accumulation of azithromycin by cultured human fibroblasts.

Authors:  R P Gladue; M E Snider
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

7.  The macrolide roxithromycin impairs NADPH oxidase activation and alters translocation of its cytosolic components to the neutrophil membrane in vitro.

Authors:  Houria Abdelghaffar; Catherine Babin-Chevaye; Marie-Thérèse Labro
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

8.  Neutrophil responses to lipopolysaccharide. Effect of adherence on triggering and priming of the respiratory burst.

Authors:  Y Aida; M J Pabst
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

9.  Monoclonal antibody 7D5 raised to cytochrome b558 of human neutrophils: immunocytochemical detection of the antigen in peripheral phagocytes of normal subjects, patients with chronic granulomatous disease, and their carrier mothers.

Authors:  M Nakamura; M Murakami; T Koga; Y Tanaka; S Minakami
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

10.  EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts.

Authors:  Hideyuki Ikeda; Toshiaki Sunazuka; Hiromi Suzuki; Yoichiro Hamasaki; Soji Yamazaki; Satoshi Omura; Atsushi Hatamochi
Journal:  J Dermatol Sci       Date:  2007-11-26       Impact factor: 4.563

View more
  5 in total

1.  Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy.

Authors:  Kerstin Pohl; Xue A Grimm; Silvia M Caceres; Katie R Poch; Noel Rysavy; Milene Saavedra; Jerry A Nick; Kenneth C Malcolm
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

2.  Azithromycin oral suspension in prevention and management of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized controlled trial.

Authors:  Sayeh Parkhideh; Mohadeseh Zeraatkar; Omid Moradi; Abbas Hajifathali; Mahshid Mehdizadeh; Maria Tavakoli-Ardakani
Journal:  Support Care Cancer       Date:  2021-07-14       Impact factor: 3.603

3.  Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.

Authors:  Jie Wang; Jian-Ping Hao; Md Nazim Uddin; Yun Wu; Rong Chen; Dong-Feng Li; Dai-Qin Xiong; Nan Ding; Jian-Hua Yang; Xuan-Sheng Ding
Journal:  Aging (Albany NY)       Date:  2021-06-18       Impact factor: 5.682

4.  Urine Levels of Defensin α1 Reflect Kidney Injury in Leptospirosis Patients.

Authors:  Haorile Chagan-Yasutan; Yue Chen; Talitha Lea Lacuesta; Prisca Susan A Leano; Hiroko Iwasaki; Firmanto Hanan; Delsi Taurustiati; Yasukazu Ohmoto; Yugo Ashino; Hiroki Saitoh; Hideyasu Kiyomoto; Yasuhiko Suzuki; Freda O Elizabeth Telan; Toshio Hattori
Journal:  Int J Mol Sci       Date:  2016-09-27       Impact factor: 5.923

Review 5.  Azithromycin in viral infections.

Authors:  Madeleine E Oliver; Timothy S C Hinks
Journal:  Rev Med Virol       Date:  2020-09-23       Impact factor: 11.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.